|
Peritoneal Dialysis solutions
Important Factors in Biocompatibility of PD Solutions
Characteristics of Hypertonic glucose PD Solution
Diapositiva PPT
Diapositiva PPT
Osmolality and Biocompatibility
Osmolality
GDPs
PD solutions and GDPs
Diapositiva PPT
Diapositiva PPT
Effect of Physioneal on Leukocyte Function In Vitro Glucose Degradation Products
Diapositiva PPT
Advanced Glycation Endproducts (AGE)
GDPs and AGE Formation
Physioneal has Reduced Levels of 3-DG and Methylglyoxal Dawnay et al., 1999 ASN Abstracts
Diapositiva PPT
Diapositiva PPT
Amadori product formation
Diapositiva PPT
Diapositiva PPT
Diapositiva PPT
Diapositiva PPT
Metabolic potential of hypertonic glucose PD Solution
Diapositiva PPT
Hyperleptinemia 1
Hyperleptinemia 2
Characteristics of Icodextrin PD Solution (7.5%)
Ultrafiltration with Icodextrin in CAPD
Ultrafiltration with Icodextrin in CAPD
Metabolism of Icodextrin
Serum Levels of Icodextrin and Metabolites
Pharmacokinetics of Icodextrin
Ultrafiltration Kinetics of Icodextrin Exchanges
Ultrafiltration with Icodextrin during Peritonitis CAPD
Ultrafiltration with Icodextrin during Peritonitis CCPD
Study Description
UF Comparison for Glucose (Daytime Exchanges) and Icodextrin (Nightime Exchange) during 9 Peritonitis Episodes
Conclusion
Skin Reactions (SR) 1
Skin Reactions (SR) 2
Serum Amylase 1
Serum Amylase 2
Icodextrin and Glucose tests
EFFECTS OF PERITONEAL DIALYSIS WITH AN OVERNIGHT ICODEXTRIN DWELL ON PARAMETERS OF GLUCOSE AND LIPID METABOLISM
Study design
Results
Extraneal™ May Extend CAPD Technique Survival in Patients with UF Failure
Effects of icodextrin in APD on blood pressure and bioelectrical impedance analysis
Study Description
Summary of Results
CONCLUSION
Diapositiva PPT
Enhancing nutrition management
Protein-Energy Malnutrition
How Do We Identify Malnutrition?
Tools for Nutrition Assessment
Albumin as a Predictor
Albumin as a Negative Acute Phase Reactant
Diapositiva PPT
Diapositiva PPT
Malnutrition is Common in HD
Prevalence of Malnutrition is Similar in HD and PD*
Target Protein Intake for PD
How Can This Target Be Achieved?
Diapositiva PPT
Malnutrition in ESRD Aims of Intraperitoneal AA
Nutrineal ® Characteristics
Relationship between Protein Intake and Phosphorus Intake
Diapositiva PPT
Nutrineal Absorption Study
Diapositiva PPT
Managing Protein Needs with Nutrineal
Diapositiva PPT
Nitrogen Balance Study
Diapositiva PPT
Addressing Malnutrition in PD
Effects of an AA dialysate on leucine metabolism in CAPD patients
Study Description
Conclusion
Acute effects of peritoneal dialysis with dialysates containing dextrose or dextrose and AA on muscle protein turnover in patients with chronic renal failure
Study Description
RESULTS: PD with dextrose
RESULTS: PD with dextrose + AA
Conclusion
Diapositiva PPT
Important Factors in Biocompatibility of PD Solutions
PHYSIONEAL FORMULATION
The Product
Diapositiva PPT
Study Design
Diapositiva PPT
Pain Severity Rating Scale Peak Pain During Infusion
McGill Pain Questionnaire
Phase III STUDY DESIGN
Plasma Bicarbonate:(ITT)
PHASE III STUDY
Diapositiva PPT
Diapositiva PPT
Effect of Bic/Lac PD Solution on Leukocyte Function In Vitro Glucose Degradation Products
Advanced Glycation End-products (AGE)
Diapositiva PPT
Diapositiva PPT
Diapositiva PPT
Diapositiva PPT
Diapositiva PPT
What do the changes in peritoneal markers really mean ?
Phase III Effluent CA125 levels
Diapositiva PPT
Diapositiva PPT
PD solution portfolio biocompatibility profile
Diapositiva PPT
Diapositiva PPT
Diapositiva PPT
Diapositiva PPT
Diapositiva PPT
Experimental model
Aims
Exp.1. Effect of conventional PDF on appetitein rats
Diapositiva PPT
Diapositiva PPT
Diapositiva PPT
Aims: To test the effect of GDP produced in different sterilized conditions and osmolality of PDF on appetite?
Diapositiva PPT
Diapositiva PPT
Summary & Conclusion
Diapositiva PPT
Patient case 1: Hospital Dr.Negrin Las Palmas, Canaria Islands
Patient case 1: Hospital Dr.Negrin Las Palmas, Canaria Islands
Patient case 2 Hospital Dr.Negrin Las Palmas, Canaria Islands
Patient case 2: Hospital Dr.Negrin Las Palmas, Canaria Islands
Patient case 3: Hospital Dr.Negrin Las Palmas, Canaria Islands
Patient case 3 : Hospital Dr.Negrin Las Palmas, Canaria Islands
|
